Nordic Nanovector to present at 3rd Targeted Radiopharmaceutical Summit 2021
Published on: Monday 06 December 2021
OSLO, Norway, Dec. 7, 2021 /PRNewswire/ -- Nordic Nanovector ASA (OSE: NANOV), a clinical-stage biotech company focused on CD37-targeted therapies for haematological cancers and immune diseases ...